References
- Bell D. Y., Naseman J. A., Spock A., McLennon G., Hook G. E. Plasma proteins of the bronchealveolar surface of the lungs of smokers and nonsmokers. Am. Rev. Respir. Dis. 1981; 124: 72–79
- Bhalla D. K., Young C. Effects of acute exposure to O3 on rats: Sequence of epithelial and inflammatory changes in the distal airways. Inhal. Toxicol. 1992; 4: 17–31
- Damji K. S., Sherwin R. P. The effect of ozone and simulated high altitude on murine lung elastin: Quantitation by image analysis. Toxicol. Ind. Health 1989; 5: 995–1003
- Devlin R. B., Koren H. S. The use of quantitative two-dimensional gel electrophoresis to analyze changes in alveolar macrophage proteins in humans exposed to ozone. Am. J. Respir. Cell Mol. Biol. 1990; 2: 281–288
- Gallagher S. R., Smith J. A. Analysis of proteins. Current Protocols in Molecular Biology, F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Struhl. Wiley, New York 1991; 1001–10220
- Hesterberg T. W., Last J. A. Ozone-induced acute pulmonary fibrosis in rats. Am. Rev. Respir. Dis. 1981; 123: 47–52
- Hubbard R. C., Crystal R. G. Antiproteases. The Lung: Scientific Foundations, R. G. Crystal, J. B. West, P. J. Barnes, N. S. Cherniack, E. R. Weibel. Raven Press, New York 1991; 1775–1788
- Hubbard R. C., Brantly M. L., Crystal R. G. Proteases. The Lung: Scientific Foundations, R. G. Crystal, J. B. West, P. T. Barnes, N. S. Cherniack, E. R. Weibel. Raven Press, New York 1991; 1763–1773
- Johnson D. A. Ozone inactivation of human α1-proteinase inhibitor. Am. Rev. Respir. Dis. 1980; 121: 1031–1038
- Johnson D. A. Effects of ozone and nitrogen dioxide on human lung protease inhibitors. Research Report No. 11. Health Effects Institute, Cambridge, Mass 1987
- Johnson D. A., Winters R. S., Woolley T., Graham D., Henderson F. W. Ozone effects on alpha-1-proteinase inhibitor in vivo: Blood plasma inhibitory activity is unchanged. Exp. Lung Res. 1986; 11: 95–103
- Koren H. S., Devlin R. B., Graham D. E., Mann R., McGee M. P., Horstman D. H., Kozumbo W. J., Becker S., House D. E., McDonnell W. F., Bromberg P. A. Ozone-induced inflammation in the lower airways of human subjects. Am. Rev. Respir. Dis. 1989; 139: 407–415
- Nadziejko C. E., Nansen L., Mannix R. C., Kleinman M. T., Phalen R. F. Effect of nitric acid vapor on the response to inhaled ozone. Inhal. Toxicol. 1992; 4: 343–358
- Parks W. C. Localization of tropoelastin and type I procollagen expression in lungs after short-term ozone exposure. HEI Communication Number 1. Health Effects Institute, Cambridge, Mass 1992; 12–15
- Reiser K. M., Tyler W. S., Hennessy S. M., Dominguez J. J., Last J. A. Long-term consequences of exposure to ozone. II. Structural alterations in lung collagen of monkeys. Toxicol. Appl. Pharmacol. 1987; 89: 314–322
- Roll D. E., Glew R. H. Isolation and characterization of rat α-1-antitrypsin. J. Biol Chem. 1981; 256: 8190–8196
- Warren D. L., Guth D. J., Last J. A. Synergistic interaction of ozone and respirable aerosols on rat lungs. II. Synergy between ammonium sulfate aerosol and various concentrations of ozone. Toxicol. Appl. Pharmacol. 1986; 84: 470–479
- White R., Lee D., Habieht G. S., Janoff A. Secretion of alpha-1-proteinase inhibitor by cultured rat alveolar macrophages. Am. Rev. Respir. Dis. 1981; 123: 447–449